Clinical trial Recruiting at 4 sites Interventional Ages 18 to 65

Investigating the link between obesity and infectious diseases with diet and melatonin

Official title: PRIN "SIDERALE": Susceptibility to Infectious Diseases in obEsity: an endocRine trAnslational socioLogic Evaluation

Run by Federico II University · NCT06236932 · Data updated 2026-11-12

This study is testing how obesity affects the risk of getting infections and whether a Mediterranean diet and melatonin can help people with obesity and related health issues feel better.

More Obesity trials

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment100 (estimated)
SponsorFederico II University
Academic / other
Locations4 sites (Naples and 3 other locations)
StatusRecruiting
StartedDecember 29, 2023
Main results expectedOctober 29, 2025
Study endsOctober 29, 2026
Registry record updatedAugust 12, 2025
Trial IDNCT06236932 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18-65 with a BMI of 30-35 kg/m2, including those with essential obesity, genetic obesity, or obesity-related conditions.

Probably not a fit

Patients who are pregnant, breastfeeding, or have severe health conditions such as cardiac or liver diseases may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project explores how obesity affects susceptibility to infectious diseases and the potential benefits of a Mediterranean diet and melatonin supplementation. It aims to enroll patients with essential and genetic forms of obesity, as well as those with obesity-related conditions like Type 2 diabetes and lipodystrophy. The study will assess the relationship between dietary habits, gut microbiota, and infection rates, while also examining the impact of lifestyle factors on health outcomes. Structured questionnaires will be used to gather data on biomedical values and environmental conditions.

Why it matters

Potential benefit: If successful, this study could lead to improved dietary and treatment strategies for obese patients to reduce their risk of infections.

How similar studies have gone: While the role of diet and melatonin in obesity has been explored, this specific approach to linking these factors with infectious disease susceptibility is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* essential obesity (BMI : 30-35 Kg/m2)
* genetic forms of obesity (BMI: 30-35 Kg/m2)
* obesity (BMI:30-35 Kg/m2) associated with T2DM
* obesity (BMI:30-35 Kg/m2) associated with endocrinopathies
* lipodystrophy

Exclusion Criteria:

* pregnancy, breast-feeding, alcohol and drug abuse, known severe haematological, cardiac, liver, kidney, mental diseases, hypogonadisms, hormonal treatments including estroprogestins, intolerance to melatonin or excipients

Where it's running

  • "Federico II" University of Naples, Department of Clinical and Molecular Endocrinology and Oncology
    Naples, Italy
    Recruiting
  • Università del Piemonte Orientale
    Novara, Italy
    Recruiting
  • University of Pisa
    Pisa, Italy
    Recruiting
  • "Sapienza" University of Rome
    Roma, Italy
    Recruiting

Study contacts

  • Principal investigator: Annamaria Colao, Prof — Federico II University
  • Study coordinator: Annamaria Colao, Prof
  • Email: colao@unina.it
  • Phone: +393285390000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.